CellerateRX Surgical is distributed by Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc. Our primary focus is the distribution of this unique, patented collagen product line which is FDA-cleared for all wound types except 3rd degree burns. CellerateRX Surgical was introduced in the fall of 2012 and has been used in more than 8,500 surgeries across the US.
Since our inception, Wound Management Technologies, Inc. has pursued innovation and growth — we hold licenses and patents to technologies and processes that have transformed healthcare delivery and positively impacted clinical outcomes. We develop, market and distribute a suite of biotechnology products to physicians, clinics and hospitals in the U.S. and abroad. With a robust presence in the $5B worldwide advanced wound care market, we have a strong history of developing long-term strategic partnerships and a focus on high-tech products that fuse nature with science in the operating room and beyond.
A sister subsidiary, Resorbable Orthopedic Products, owns a multi-faceted bone wax and bone void filler patent and markets products in the $1.5B biomaterials market. in February 2016 we received FDA 510(k) clearance for a resorbable hemostat for bone bleeding.
HemaQuell™ Resorbable Bone Wax will be available for first cases in the 3rd Quarter of 2016 with a full market roll-out afterwards.
For more information on Wound Management Technologies, please visit www.wmgtech.com
DESIGNED BY NATURE ♦ ACTIVATED BY SCIENCE
Copyright © 2018 All Rights Reserved, Wound Care Innovations, LLC – A WNDM Medical, Inc. company.
CellerateRX® is a trademark of Applied Nutritionals, LLC. Activated Collagen® and CRXα® are trademarks of WNDM Medical, Inc.